ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "IMpower 110 & Checkmate 153"
Episode Synopsis
Another week, another 2 studies of checkpoint inhibitors in NSCLC to talk about.
IMpower 110: https://www.nejm.org/doi/full/10.1056/NEJMoa1917346
Checkmate-153: https://ascopubs.org/doi/full/10.1200/JCO.20.00131
IMpower 110: https://www.nejm.org/doi/full/10.1056/NEJMoa1917346
Checkmate-153: https://ascopubs.org/doi/full/10.1200/JCO.20.00131
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust